Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-31 @ 9:14 PM
Study NCT ID:
NCT07454720
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-03-06
First Post:
2026-02-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II/III Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer
Sponsor:
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-03
Start Date Type:
ESTIMATED
Primary Completion Date:
2032-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2035-11
Completion Date Type:
ESTIMATED
First Submit Date:
2026-02-25
First Submit QC Date:
None
Study First Post Date:
2026-03-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-03-03
Last Update Post Date:
2026-03-06
Last Update Post Date Type:
ACTUAL